A Dose Ascending Study to Evaluate the Safety of NH002 as a Contrast Agent in Cardiac Echocardiography
Clinical trial NCT04185246 · COMPLETED
Trial details
- NCT number
- NCT04185246
- Sponsor
- Trust Bio-sonics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-04
- Primary completion
- 2020-07-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.